H. Michael Shepard

2009

In 2009, H. Michael Shepard earned a total compensation of $802.8K as Vice President and Chief Scientific Officer at Halozyme Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$32,603
Option Awards$557,390
Salary$152,744
Other$60,112
Total$802,849

Shepard received $557.4K in option awards, accounting for 69% of the total pay in 2009.

Shepard also received $32.6K in non-equity incentive plan, $152.7K in salary and $60.1K in other compensation.

Rankings

In 2009, H. Michael Shepard's compensation ranked 5,169th out of 9,885 executives tracked by ExecPay. In other words, Shepard earned more than 47.7% of executives.

ClassificationRankingPercentile
All
5,169
out of 9,885
48th
Division
Manufacturing
1,852
out of 3,690
50th
Major group
Chemicals And Allied Products
382
out of 871
56th
Industry group
Drugs
238
out of 643
63rd
Industry
Biological Products, Except Diagnostic Substances
44
out of 138
68th
Source: SEC filing on March 29, 2012.

Shepard's colleagues

We found eight more compensation records of executives who worked with H. Michael Shepard at Halozyme Therapeutics in 2009.

2009

Jonathan Leff

Halozyme Therapeutics

Chief Medical Officer

2009

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

2009

Jonathan Lim

Halozyme Therapeutics

Chief Executive Officer

2009

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2009

William Fallon

Halozyme Therapeutics

Vice President, Manufacturing & Operations

2009

David Ramsay

Halozyme Therapeutics

Vice President Corporate Development

2009

Robert Little

Halozyme Therapeutics

Vice President and Chief Commercial Officer

2009

Michael LaBarre

Halozyme Therapeutics

Vice President, Product Development

In-depth

You may also like